Targeting rare diseases with adenosine modulators

The Vision of Palobiofarma is to discover the first marketed drug based on a selective adenosine receptor modulator.

How do we achieve our vision

Palobiofarma focused internal resources on areas where lies the experience of the management team::

• Virtual drug design
• Medicinal Chemistry
• In Vitro Pharmacology of adenosine
• Physico-chemical characterization of the compounds
• Intellectual Property

The remaining activities needed for the full compound characterization and the nomination of a development candidate, such as the pharmacology and toxicology tests, are carried out through partnerships with various companies (CROs), Research Centres and Universities.